Jazz Pharmaceuticals selects Microsoft Entra ID (formerly Azure Active Directory) for Identity and Access Management (IAM)

In 2023, Jazz Pharmaceuticals, a Ireland based Life Sciences organization with 2800 employees and revenues of $3.8B selected Microsoft Entra ID (formerly Azure Active Directory) for Identity and Access Management (IAM) while displacing Legacy, and integrating with the existing systems being used.

Customer Vendor Old Product New Product Category Market Users VAR/SI When Live
Jazz Pharmaceuticals Microsoft Legacy Microsoft Entra ID (formerly Azure Active Directory) Identity and Access Management (IAM) CyberSecurity n/a n/a 2023 2023
Discover the latest software purchases and digital transformation initiatives being undertaken by Jazz Pharmaceuticals and its business and technology executives by accessing the entire Jazz Pharmaceuticals and its business and technology executives by becoming a Premium Subscriber. On a continuous basis, our research team identifies and updates the on-prem and cloud applications that are being used by Jazz Pharmaceuticals employees from publicly available data (Press Releases, Customer References, Case Studies, Success Stories, Testimonials, RFP, RFI, etc.) as well as proprietary sources, and incorporate them into the customer profile.

Don't miss the entire: Jazz Pharmaceuticals Technographics profile